製品# | サイズ | 数量 | 価格 | 在庫 |
---|---|---|---|---|
75352T | 1 Kit (9 x 20 microliters) |
|
Product Includes | Quantity | Applications | Reactivity | MW(kDa) | Isotype |
---|---|---|---|---|---|
ACE2 Antibody 4355 | 20 µl |
|
H | 120-135 | Rabbit |
DPP4/CD26 (D6D8K) Rabbit mAb 67138 | 20 µl |
|
H | 90, 120 | Rabbit IgG |
CD13/APN (D6V1W) Rabbit mAb 32720 | 20 µl |
|
H M R | 160 | Rabbit IgG |
Basigin/EMMPRIN (E1S1V) Rabbit mAb 13287 | 20 µl |
|
H | 38-58 | Rabbit IgG |
EEA1 (C45B10) Rabbit mAb 3288 | 20 µl |
|
H M R | 170 | Rabbit IgG |
IFITM1 Antibody 13126 | 20 µl |
|
H | 14 | Rabbit |
Cathepsin B (D1C7Y) XP® Rabbit mAb 31718 | 20 µl |
|
H M R | 44, 27, 24 | Rabbit IgG |
IFITM3 (D8E8G) XP® Rabbit mAb 59212 | 20 µl |
|
H | 15 | Rabbit IgG |
VCP (7F3) Rabbit mAb 2649 | 20 µl |
|
H M R Mk | 89 | Rabbit IgG |
Anti-rabbit IgG, HRP-linked Antibody 7074 | 100 µl |
|
Rab | Goat |
製品情報
Monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu491 of human DPP4 protein, Ala254 of human EMMPRIN protein, Ser70 of human EEA1 protein, Val5 of human IFITM3 protein, and a synthetic peptide corresponding to the sequence of human VCP. Monoclonal antibodies are produced by immunizing animals with a recombinant protein specific to the carboxy terminus of human CD13/APN protein and a recombinant protein specific to the heavy chain subunit of human cathepsin B protein. Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues near the carboxy terminus of human ACE2 protein and surrounding Pro20 of human IFITM1 protein. Polyclonal antibodies are purified by protein A and peptide affinity chromatography.
Coronaviruses are a group of viruses that contain single-stranded, positive-sense RNA genomes. Several members of this group, which include severe acute respiratory syndrome coronaviruses (SARS-CoV and SARS-CoV-2) and Middle East respiratory syndrome coronavirus (MERS-CoV), are highly pathogenic and have caused significant disease outbreaks in human hosts. In order for human coronaviruses to transcribe and replicate their genomes within host cells, they must first attach and gain entry into host cells using a variety of cell surface receptors and components of the endocytic machinery.
ACE2 is a carboxypeptidase that catalyses the conversion of angiotensin I to angiotensin 1-9, or of angiotensin II to the vasodilator angiotensin 1-7 (1). Research studies have identified ACE2 as the receptor for SARS and SARS-CoV-2 coronaviruses (2-4).
DPP4 (CD26) is a type II transmembrane glycoprotein expressed ubiquitously in most tissues and different cell types (5,6). In addition to its peptidase activity, DPP4 interacts with multiple important cell surface ligands, such as adenosine deaminase, fibronectin, and IGF2 receptor to influence processes like T cell activation, cell migration, and proliferation (7). Research studies have shown that DPP4 serves as a cellular receptor for the MERS-CoV spike protein (8).
Aminopeptidase N (APN, CD13) is a widely expressed, membrane-bound proteolytic enzyme that breaks down peptides during digestion, cleaves cell surface antigens during antigen presentation, and acts as a receptor for human viruses, including several coronaviruses. This multifunctional protein is implicated in the regulation of many biological processes, including angiogenesis, cell proliferation, cell migration, inflammation, and immune response (9,10).
Basigin (EMMPRIN, CD147) is a type I integral membrane receptor protein belonging to the immunoglobulin superfamily (11). Multiple functions have been ascribed to Basigin; foremost among these is stimulating the secretion of extracellular matrix metalloproteinases by adjacent fibroblasts, a function which has been implicated in promoting tumor progression (12-14). Research studies have suggested that Basigin serves as a novel host cell surface receptor for SARS-CoV-2 (15).
EEA1 is an early endosomal marker and a Rab5 effector protein essential for early endosomal membrane fusion and trafficking (16,17). Research studies have shown that efficient coronavirus host cell entry and replication relies upon early endosomes containing EEA1 (18).
Interferon-induced transmembrane protein (IFITM) family members are composed of short amino- and carboxy-termini, two transmembrane domains, and a cytoplasmic domain (19). The primary function of IFITM family proteins appears to be viral restriction, as IFITM proteins inhibit cytosolic entry of coronaviruses by preventing fusion of viral and host membranes (20,21).
Valosin-containing protein (VCP) is a highly conserved and abundant 97 kDa protein that belongs to the AAA family of proteins. These protein complexes participate in many cellular functions, including vesicle transport and fusion, fragmentation and reassembly of the golgi stacks during mitosis, nuclear envelope formation and spindle disassembly following mitosis, cell cycle regulation, DNA damage repair, apoptosis, B and T cell activation, NF-κB-mediated transcriptional regulation, endoplasmic reticulum (ER)-associated degradation, and protein degradation (22). Research studies have shown that VCP facilitates the release of some coronaviruses from the early endosomal compartment (23).
Cathepsin B, part of the papain family of proteases, is a widely expressed lysosomal cysteine endopeptidase (24,25). Research studies have suggested that cathepsin B facilitates host cell entry of SARS-CoV by promoting fusion of viral and endosomal membranes (26).
法的な権限を与えられたCSTの担当者が署名した書面によって別途明示的に合意された場合を除き、 CST、その関連会社または代理店が提供する製品には以下の条件が適用されます。お客様が定める条件でここに定められた条件に含まれるものを超えるもの、 または、ここに定められた条件と異なるものは、法的な権限を与えられたCSTの担当者が別途書面にて受諾した場合を除き、拒絶され、 いかなる効力も効果も有しません。
研究専用 (For Research Use Only) またはこれに類似する表示がされた製品は、 いかなる目的についても FDA または外国もしくは国内のその他の規制機関により承認、認可または許可を受けていません。 お客様は製品を診断もしくは治療目的で使用してはならず、また、製品に表示された内容に違反する方法で使用してはなりません。 CST が販売または使用許諾する製品は、エンドユーザーであるお客様に対し、使途を研究および開発のみに限定して提供されるものです。 診断、予防もしくは治療目的で製品を使用することまたは製品を再販売 (単独であるか他の製品等の一部であるかを問いません) もしくはその他の商業的利用の目的で購入することについては、CST から別途許諾を得る必要があります。 お客様は以下の事項を遵守しなければなりません。(a) CST の製品 (単独であるか他の資材と一緒であるかを問いません) を販売、使用許諾、貸与、寄付もしくはその他の態様で第三者に譲渡したり使用させたりしてはなりません。また、商用の製品を製造するために CST の製品を使用してはなりません。(b) 複製、改変、リバースエンジニアリング、逆コンパイル、 分解または他の方法により製品の構造または技術を解明しようとしてはなりません。また、 CST の製品またはサービスと競合する製品またはサービスを開発する目的で CST の製品を使用してはなりません。(c) CST の製品の商標、商号、ロゴ、特許または著作権に関する通知または表示を除去したり改変したりしてはなりません。(d) CST の製品をCST 製品販売条件(CST’s Product Terms of Sale) および該当する書面のみに従って使用しなければなりません。(e) CST の製品に関連してお客様が使用する第三者の製品またはサービスに関する使用許諾条件、 サービス提供条件またはこれに類する合意事項を遵守しなければなりません。